Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.

Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators.

Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1. Erratum in: Lancet. 2020 Jan 25;395(10220):272. Lancet. 2020 Feb 22;395(10224):564.

PMID:
31679945
2.

NTCP model validation method for DAHANCA patient selection of protons versus photons in head and neck cancer radiotherapy.

Hansen CR, Friborg J, Jensen K, Samsøe E, Johnsen L, Zukauskaite R, Grau C, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Eriksen JG, Overgaard J.

Acta Oncol. 2019 Oct;58(10):1410-1415. doi: 10.1080/0284186X.2019.1654129. Epub 2019 Aug 21.

PMID:
31432744
3.

Head and neck cancer management in the Nordic countries: an effort to harmonize treatment.

Mäkitie AA, Cange HH, Hammarstedt-Nordenvall L, Gudjonsson A, Jóhannsson J, Laranne J, Mäenpää H, Rikardsen O, Bratland Å, Wessel I, Johansen J, Grau C.

Eur Arch Otorhinolaryngol. 2017 May;274(5):2363-2365. doi: 10.1007/s00405-017-4456-4. Epub 2017 Jan 25. No abstract available.

PMID:
28124110
4.

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.

Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T.

Eur Heart J. 2016 Jun 1;37(21):1671-80. doi: 10.1093/eurheartj/ehw022. Epub 2016 Feb 21.

5.

Man with macrocephaly, learning disability and multiple basal cell carcinomas.

von der Lippe C, Roscher I, Nordgarden H, Rustad C, Larsen SM, Mjøen E, Bratland Å.

Tidsskr Nor Laegeforen. 2014 Jun 17;134(11):1151-4. doi: 10.4045/tidsskr.13.0894. eCollection 2014 Jun 17. English, Norwegian.

6.

[Cardioprotective treatment during adjuvant cancer therapy].

Gulati G, Heck SL, Ree AH, Gravdehaug B, Røsjø H, Steine K, Bratland Å, Hoffmann P, Geisler J, Omland T.

Tidsskr Nor Laegeforen. 2013 Sep 17;133(17):1832-6. doi: 10.4045/tidsskr.12.1514. Review. Norwegian.

7.

Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer.

Røe K, Bratland Å, Vlatkovic L, Ragnum HB, Saelen MG, Olsen DR, Marignol L, Ree AH.

PLoS One. 2013 May 10;8(5):e63723. doi: 10.1371/journal.pone.0063723. Print 2013.

8.

Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial.

Heck SL, Gulati G, Ree AH, Schulz-Menger J, Gravdehaug B, Røsjø H, Steine K, Bratland A, Hoffmann P, Geisler J, Omland T.

Cardiology. 2012;123(4):240-7. doi: 10.1159/000343622. Epub 2012 Nov 30.

9.

Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy.

Bratland A, Dueland S, Hollywood D, Flatmark K, Ree AH.

Radiat Oncol. 2011 Apr 8;6:33. doi: 10.1186/1748-717X-6-33.

10.

Preoperative radiotherapy in rectal signet-ring cell carcinoma - magnetic resonance imaging and treatment outcome: Report of six cases.

Bratland A, Vetrhus T, Grøholt KK, Ree AH.

Acta Oncol. 2010;49(1):42-9. doi: 10.3109/02841860903081897.

PMID:
20100143
11.

Studies on the possibility of vertical transmission of Norwegian salmonid Alphavirus in production of Atlantic salmon in Norway.

Bratland A, Nylund A.

J Aquat Anim Health. 2009 Sep;21(3):173-8. doi: 10.1577/H08-038.1.

PMID:
20043403
12.

Osteoblast-induced EGFR/ERBB2 signaling in androgen-sensitive prostate carcinoma cells characterized by multiplex kinase activity profiling.

Bratland A, Boender PJ, Høifødt HK, Østensen IH, Ruijtenbeek R, Wang MY, Berg JP, Lilleby W, Fodstad Ø, Ree AH.

Clin Exp Metastasis. 2009;26(5):485-96. doi: 10.1007/s10585-009-9248-9. Epub 2009 Mar 18.

PMID:
19294521
13.

[Molecular targeted therapy in colorectal cancer].

Ree AH, Bratland A, Dueland S.

Tidsskr Nor Laegeforen. 2008 Jan 17;128(2):190-3. Review. Norwegian.

14.

Tissue tropism of salmonid alphaviruses (subtypes SAV1 and SAV3) in experimentally challenged Atlantic salmon (Salmo salar L.).

Andersen L, Bratland A, Hodneland K, Nylund A.

Arch Virol. 2007;152(10):1871-83. Epub 2007 Jun 20.

PMID:
17578649
15.

Transmission of infectious salmon anaemia virus (ISAV) in farmed populations of Atlantic salmon (Salmo salar).

Nylund A, Plarre H, Karlsen M, Fridell F, Ottem KF, Bratland A, Saether PA.

Arch Virol. 2007 Jan;152(1):151-79. Epub 2006 Aug 28.

PMID:
16941061
16.

Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition.

Flatmark K, Nome RV, Folkvord S, Bratland A, Rasmussen H, Ellefsen MS, Fodstad Ø, Ree AH.

Radiat Oncol. 2006 Aug 3;1:25.

17.

DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting.

Ree AH, Stokke T, Bratland A, Patzke S, Nome RV, Folkvord S, Meza-Zepeda LA, Flatmark K, Fodstad O, Andersson Y.

Anticancer Res. 2006 May-Jun;26(3A):1909-16.

18.

Functional dissection of the HNF-1alpha transcription factor: a study on nuclear localization and transcriptional activation.

Bjørkhaug L, Bratland A, Njølstad PR, Molven A.

DNA Cell Biol. 2005 Nov;24(11):661-9.

PMID:
16274290
19.

New subtype of salmonid alphavirus (SAV), Togaviridae, from Atlantic salmon Salmo salar and rainbow trout Oncorhynchus mykiss in Norway.

Hodneland K, Bratland A, Christie KE, Endresen C, Nylund A.

Dis Aquat Organ. 2005 Sep 5;66(2):113-20. Erratum in: Dis Aquat Organ. 2005 Nov 9;67(1-2):181.

20.

Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death.

Nome RV, Bratland A, Harman G, Fodstad O, Andersson Y, Ree AH.

Mol Cancer Ther. 2005 Aug;4(8):1231-8.

21.

Potentiation of cell killing by fractionated radiation and suppression of proliferative recovery in MCF-7 breast tumor cells by the Vitamin D3 analog EB 1089.

DeMasters GA, Gupta MS, Jones KR, Cabot M, Wang H, Gennings C, Park M, Bratland A, Ree AH, Gewirtz DA.

J Steroid Biochem Mol Biol. 2004 Dec;92(5):365-74. Epub 2004 Dec 21.

PMID:
15698541
22.
23.

Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner.

Ree AH, Bratland A, Solberg Landsverk K, Fodstad O.

Anticancer Res. 2004 Mar-Apr;24(2B):555-62.

24.

Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1.

Ree AH, Bratland A, Nome RV, Stokke T, Fodstad Ø.

Oncogene. 2003 Dec 4;22(55):8952-5.

PMID:
14654792
25.

The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.

Bratland A, Ragnhildstveit E, Bjørnland K, Andersen K, Maelandsmo GM, Fodstad O, Saatcioglu F, Ree AH.

Clin Exp Metastasis. 2003;20(6):541-7.

PMID:
14598888
26.

Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases.

Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM.

Anticancer Res. 2002 Jul-Aug;22(4):1949-57.

PMID:
12174869
27.

Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells.

Bjørnland K, Bratland A, Rugnes E, Pettersen S, Johansen HT, Aasen AO, Fodstad Ø, Ree AH, Maelandsmo GM.

J Pediatr Surg. 2001 Jul;36(7):1040-4.

PMID:
11431772
28.

Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells.

Bratland A, Risberg K, Maelandsmo GM, Gützkow KB, Olsen OE, Moghaddam A, Wang MY, Hansen CM, Blomhoff HK, Berg JP, Fodstad O, Ree AH.

Cancer Res. 2000 Oct 1;60(19):5578-83.

29.

[A lot of ignorance: how do antibiotics behave?].

Bratland A, Nortvedt M, Moe H, Ytrebø AM.

Sykepleien. 1984 Mar 20;71(6):10-2, 33. Norwegian. No abstract available.

PMID:
6561798

Supplemental Content

Loading ...
Support Center